Clovis Oncology reported $32.59M in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.13B 73M
Acadia Pharmaceuticals ACAD:US $ 89.9M 6.78M
Acorda Therapeutics ACOR:US $ 30.07M 4.63M
Agenus AGEN:US $ 18.91M 39K
Agios Pharmaceuticals AGIO:US $ 28.26M 3.25M
Anika Therapeutics ANIK:US $ 21.27M 2.07M
Arrowhead Research ARWR:US $ 32.74M 1.12M
Astrazeneca AZN:US 3.27B 209M
AstraZeneca AZN:LN 3.27B 209M
Cerulean Pharma CERU:US $ 2.59M 168.34K
Clovis Oncology CLVS:US $ 32.59M 3.38M
Eli Lilly And LLY:US $ 1.63B 67.2M
Enanta Pharmaceuticals ENTA:US $ 12.93M 2.45M
Esperion Therapeutics ESPR:US $ 29.61M 772K
GlaxoSmithKline GSK:LN 1.96B 726M
Halozyme Therapeutics HALO:US $ 57.48M 43.64M
Heron Therapeutics HRTX:US $ 32.12M 836K
Insmed INSM:US $ 59.97M 3.23M
Intrexon XON:US $ 12.67M 6.91M
Ligand Pharmaceuticals LGND:US $ 29.17M 10.99M
Merk MRK:US $ 2.42B 118M
Mirati Therapeutics MRTX:US $ 54.23M 277K
Neurocrine Biosciences NBIX:US $ 182.8M 17.9M
Novartis NOVN:VX 3.59B 91M
Pfizer PFE:US $ 3.2B 506M
Puma Biotechnology PBYI:US $ 20.58M 174K
Rigel Pharmaceuticals RIGL:US $ 26.98M 420K
Sangamo Biosciences SGMO:US $ 15.09M 185K
Seattle Genetics SGEN:US $ 220.26M 46.03M
Ultragenyx Pharmaceutical RARE:US $ 68.14M 825K
Veracyte VCYT:US $ 39.96M 4.18M
YTE INCY:US $ 253.28M 43.69M